Artwork

Content provided by America's Healthcare Advocate and Cary Hall. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by America's Healthcare Advocate and Cary Hall or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Brisk Walking or $13k Per Year for Weight Loss Drug - We Review Options, Cost, Ozempic & Wecovy

33:52
 
Share
 

Manage episode 414772659 series 1279924
Content provided by America's Healthcare Advocate and Cary Hall. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by America's Healthcare Advocate and Cary Hall or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Whether you are wanting to lose weight, prevent Type 2 Diabetes or both, you now can consider the class of drugs described as "glucagon-like peptide-1 (GLP-1) agonists" that work by binding to GLP-1 receptors, which in turn results in lower blood sugar levels and A1C levels and are now being prescribed to reduce appetite and help with weight loss. But there is a high financial cost and you may need to stay on the drug for life. In this episode, I will discuss the latest on Ozempic and Wegovy and which is approved by the US Food and Drug Administration to treat diabetes and which to help with weight loss or to lower risk of cardiovascular disease. Then we contrast these drugs with the latest knowledge about the effectiveness of "Brisk Walking" as I bring you the latest health and well-being news in this Multi-Topic episode! I'm Cary Hall, America's Healthcare Advocate. Ep 2011 Need help or have something to share? https://www.americashealthcareadvocate.com/contact-us
  continue reading

351 episodes

Artwork
iconShare
 
Manage episode 414772659 series 1279924
Content provided by America's Healthcare Advocate and Cary Hall. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by America's Healthcare Advocate and Cary Hall or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Whether you are wanting to lose weight, prevent Type 2 Diabetes or both, you now can consider the class of drugs described as "glucagon-like peptide-1 (GLP-1) agonists" that work by binding to GLP-1 receptors, which in turn results in lower blood sugar levels and A1C levels and are now being prescribed to reduce appetite and help with weight loss. But there is a high financial cost and you may need to stay on the drug for life. In this episode, I will discuss the latest on Ozempic and Wegovy and which is approved by the US Food and Drug Administration to treat diabetes and which to help with weight loss or to lower risk of cardiovascular disease. Then we contrast these drugs with the latest knowledge about the effectiveness of "Brisk Walking" as I bring you the latest health and well-being news in this Multi-Topic episode! I'm Cary Hall, America's Healthcare Advocate. Ep 2011 Need help or have something to share? https://www.americashealthcareadvocate.com/contact-us
  continue reading

351 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide